DiscoverThe Genetics PodcastEP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center
EP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center

EP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center

Update: 2023-06-22
Share

Description

Join Patrick in welcoming Dr. Bettina Lundgren, CEO of the Danish National Genome Center. Bettina is spearheading the development of personalised medicine in Denmark with a focus on integrating genome sequencing directly into the healthcare system. She is dedicated to fostering international collaboration in research and healthcare delivery. Tune in to learn about the one of the leading national scale genomics initiatives, and Bettina’s r insights on the future of personalised medicine!

0:00 Intro

0:56 Bettina’s path to genomics

1:47 Aspirations of the Danish National Genome Center

4:18 Comparing the Danish National Genome Center to other global genomics programs

8:10 Goal to sequence 60,000 whole genomes by 2024

11:40 The biggest challenges of integrating genomics with healthcare

15:30 Navigating the politics of privacy and data sharing

20:02 Complexities of sharing data across diverse regions and healthcare systems

23:28 Partnerships across borders: Sweden, Europe, and the world

28:10 Looking forward 10 years: strategies and novel developments in personalised healthcare

31:25 Final Thoughts

32:37 Outro
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

EP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center

EP101: Fostering international progress towards personalised medicine with Dr. Bettina Lundgren, CEO of the Danish National Genome Center

Sano Genetics